News

Biosimilars Bi-weekly Update – February 27, 2017


IHE Life Sciences Open Innovation Platform™
What's new and exciting: Top three supported ideas!

  • Using existing infrastructure to track outcomes
    utilize existing health IT infrastructure to track biosimilar utilization and outcomes, as opposed to creating separate national or multiple provincial patient registries
  • Avoid non-medical switching
    no non-medical switching of innovator biologics to biosimilars until there is unequivocal evidence supporting its safety
  • Robust patient engagement
    support an environment of robust patient association involvement in this discussion to understand how this affects individuals beyond the clinic

One month left to provide feedback for the IHE forum at the CADTH 2017 meeting!

If you have an idea, or wish to provide feedback for any existing ideas, logon to the IHE Life Sciences Open Innovation Platform™. Your input is welcome and greatly appreciated!

Register or logon here:  IHE Life Sciences Open Innovation Platform™
 


IHE Life Sciences Open Innovation Platform Video

 


Downloads